HEADER TRANSFERASE/INHIBITOR 29-JUN-22 7YBP TITLE CRYSTAL STRUCTURE OF FGFR4(V550L) KINASE DOMAIN WITH 10Z COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBROBLAST GROWTH FACTOR RECEPTOR 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: FGFR-4; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FGFR4, JTK2, TKF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, INHIBITOR, STRUCTURAL PROTEIN, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.J.CHEN,Q.M.LIN,Y.H.CHEN REVDAT 3 29-NOV-23 7YBP 1 REMARK REVDAT 2 23-NOV-22 7YBP 1 JRNL REVDAT 1 16-NOV-22 7YBP 0 JRNL AUTH F.YANG,X.CHEN,X.SONG,R.ORTEGA,X.LIN,W.DENG,J.GUO,Z.TU, JRNL AUTH 2 A.V.PATTERSON,J.B.SMAILL,Y.CHEN,X.LU JRNL TITL DESIGN, SYNTHESIS, AND BIOLOGICAL EVALUATION OF JRNL TITL 2 5-FORMYL-PYRROLO[3,2- B ]PYRIDINE-3-CARBOXAMIDES AS NEW JRNL TITL 3 SELECTIVE, POTENT, AND REVERSIBLE-COVALENT FGFR4 INHIBITORS. JRNL REF J.MED.CHEM. V. 65 14809 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 36278929 JRNL DOI 10.1021/ACS.JMEDCHEM.2C01319 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.85 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 14435 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 721 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.8450 - 3.8346 1.00 2830 161 0.1543 0.1817 REMARK 3 2 3.8346 - 3.0439 0.99 2816 133 0.1724 0.2237 REMARK 3 3 3.0439 - 2.6592 0.99 2737 151 0.2009 0.2445 REMARK 3 4 2.6592 - 2.4161 0.98 2738 149 0.2073 0.2300 REMARK 3 5 2.4161 - 2.2430 0.93 2593 127 0.1903 0.2418 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.200 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2475 REMARK 3 ANGLE : 0.724 3368 REMARK 3 CHIRALITY : 0.028 356 REMARK 3 PLANARITY : 0.003 435 REMARK 3 DIHEDRAL : 13.409 937 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 205.0782 6.4574 133.7154 REMARK 3 T TENSOR REMARK 3 T11: 0.2173 T22: 0.2305 REMARK 3 T33: 0.2222 T12: -0.0097 REMARK 3 T13: 0.0170 T23: 0.0007 REMARK 3 L TENSOR REMARK 3 L11: 0.3967 L22: 0.5015 REMARK 3 L33: 0.5855 L12: 0.0406 REMARK 3 L13: 0.2716 L23: -0.1419 REMARK 3 S TENSOR REMARK 3 S11: 0.0096 S12: -0.0127 S13: 0.0012 REMARK 3 S21: -0.0378 S22: -0.0325 S23: -0.0010 REMARK 3 S31: 0.0370 S32: -0.0000 S33: 0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7YBP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 30-JUN-22. REMARK 100 THE DEPOSITION ID IS D_1300030625. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : CU FINE FOCUS REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5870 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14441 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.243 REMARK 200 RESOLUTION RANGE LOW (A) : 42.845 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.19640 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.9800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.1 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.29200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.880 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7WCT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M BIS-TRIS (PH 4.5), 0.2 M LI2SO4, REMARK 280 16-19 % PEG 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 30.59400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 445 REMARK 465 LEU A 446 REMARK 465 ALA A 447 REMARK 465 GLY A 448 REMARK 465 LEU A 449 REMARK 465 VAL A 450 REMARK 465 SER A 451 REMARK 465 LEU A 452 REMARK 465 GLU A 753 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 471 CG CD CE NZ REMARK 470 ARG A 529 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 644 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 506 -174.41 -67.36 REMARK 500 ASN A 508 56.28 -98.79 REMARK 500 ARG A 611 -6.26 73.47 REMARK 500 ASP A 612 54.70 -154.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 616 0.18 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 7YBP A 445 753 UNP P22455 FGFR4_HUMAN 445 753 SEQADV 7YBP ALA A 477 UNP P22455 CYS 477 CONFLICT SEQADV 7YBP LEU A 550 UNP P22455 VAL 550 ENGINEERED MUTATION SEQADV 7YBP GLU A 664 UNP P22455 ARG 664 ENGINEERED MUTATION SEQRES 1 A 309 LEU LEU ALA GLY LEU VAL SER LEU ASP LEU PRO LEU ASP SEQRES 2 A 309 PRO LEU TRP GLU PHE PRO ARG ASP ARG LEU VAL LEU GLY SEQRES 3 A 309 LYS PRO LEU GLY GLU GLY ALA PHE GLY GLN VAL VAL ARG SEQRES 4 A 309 ALA GLU ALA PHE GLY MET ASP PRO ALA ARG PRO ASP GLN SEQRES 5 A 309 ALA SER THR VAL ALA VAL LYS MET LEU LYS ASP ASN ALA SEQRES 6 A 309 SER ASP LYS ASP LEU ALA ASP LEU VAL SER GLU MET GLU SEQRES 7 A 309 VAL MET LYS LEU ILE GLY ARG HIS LYS ASN ILE ILE ASN SEQRES 8 A 309 LEU LEU GLY VAL CYS THR GLN GLU GLY PRO LEU TYR VAL SEQRES 9 A 309 ILE LEU GLU CYS ALA ALA LYS GLY ASN LEU ARG GLU PHE SEQRES 10 A 309 LEU ARG ALA ARG ARG PRO PRO GLY PRO ASP LEU SER PRO SEQRES 11 A 309 ASP GLY PRO ARG SER SER GLU GLY PRO LEU SER PHE PRO SEQRES 12 A 309 VAL LEU VAL SER CYS ALA TYR GLN VAL ALA ARG GLY MET SEQRES 13 A 309 GLN TYR LEU GLU SER ARG LYS CYS ILE HIS ARG ASP LEU SEQRES 14 A 309 ALA ALA ARG ASN VAL LEU VAL THR GLU ASP ASN VAL MET SEQRES 15 A 309 LYS ILE ALA ASP PHE GLY LEU ALA ARG GLY VAL HIS HIS SEQRES 16 A 309 ILE ASP TYR TYR LYS LYS THR SER ASN GLY ARG LEU PRO SEQRES 17 A 309 VAL LYS TRP MET ALA PRO GLU ALA LEU PHE ASP GLU VAL SEQRES 18 A 309 TYR THR HIS GLN SER ASP VAL TRP SER PHE GLY ILE LEU SEQRES 19 A 309 LEU TRP GLU ILE PHE THR LEU GLY GLY SER PRO TYR PRO SEQRES 20 A 309 GLY ILE PRO VAL GLU GLU LEU PHE SER LEU LEU ARG GLU SEQRES 21 A 309 GLY HIS ARG MET ASP ARG PRO PRO HIS CYS PRO PRO GLU SEQRES 22 A 309 LEU TYR GLY LEU MET ARG GLU CYS TRP HIS ALA ALA PRO SEQRES 23 A 309 SER GLN ARG PRO THR PHE LYS GLN LEU VAL GLU ALA LEU SEQRES 24 A 309 ASP LYS VAL LEU LEU ALA VAL SER GLU GLU HET IH7 A 801 42 HET SO4 A 802 5 HET SO4 A 803 5 HET SO4 A 804 5 HET SO4 A 805 5 HET SO4 A 806 5 HETNAM IH7 ~{N}-[4-[(1~{R})-1-[3,5-BIS(CHLORANYL)PYRIDIN-4- HETNAM 2 IH7 YL]ETHOXY]-5-CYANO-PYRIDIN-2-YL]-6-BROMANYL-5- HETNAM 3 IH7 (HYDROXYMETHYL)-1-(2-MORPHOLIN-4-YLETHYL)PYRROLO[3,2- HETNAM 4 IH7 B]PYRIDINE-3-CARBOXAMIDE HETNAM SO4 SULFATE ION FORMUL 2 IH7 C28 H24 BR CL2 N7 O4 FORMUL 3 SO4 5(O4 S 2-) FORMUL 8 HOH *162(H2 O) HELIX 1 AA1 PRO A 463 ASP A 465 5 3 HELIX 2 AA2 SER A 510 ILE A 527 1 18 HELIX 3 AA3 ASN A 557 ALA A 564 1 8 HELIX 4 AA4 SER A 585 ARG A 606 1 22 HELIX 5 AA5 ALA A 614 ARG A 616 5 3 HELIX 6 AA6 LEU A 651 MET A 656 5 6 HELIX 7 AA7 ALA A 657 GLU A 664 1 8 HELIX 8 AA8 THR A 667 PHE A 683 1 17 HELIX 9 AA9 PRO A 694 GLU A 704 1 11 HELIX 10 AB1 PRO A 715 TRP A 726 1 12 HELIX 11 AB2 ALA A 729 ARG A 733 5 5 HELIX 12 AB3 THR A 735 VAL A 750 1 16 SHEET 1 AA1 5 LEU A 467 GLU A 475 0 SHEET 2 AA1 5 GLN A 480 PHE A 487 -1 O ARG A 483 N GLY A 470 SHEET 3 AA1 5 ALA A 497 MET A 504 -1 O SER A 498 N ALA A 486 SHEET 4 AA1 5 TYR A 547 GLU A 551 -1 O LEU A 550 N ALA A 501 SHEET 5 AA1 5 LEU A 536 CYS A 540 -1 N LEU A 537 O ILE A 549 SHEET 1 AA2 2 VAL A 618 VAL A 620 0 SHEET 2 AA2 2 MET A 626 ILE A 628 -1 O LYS A 627 N LEU A 619 LINK SG CYS A 552 CAJ IH7 A 801 1555 1555 1.73 CRYST1 42.253 61.188 60.611 90.00 98.05 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023667 0.000000 0.003349 0.00000 SCALE2 0.000000 0.016343 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016663 0.00000